tiprankstipranks
Trending News
More News >
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market

Cell Source (CLCS) Income Statement

Compare
11 Followers

Cell Source Income Statement

Last quarter (Q3 2024), Cell Source's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cell Source's net income was $-1.42M. See Cell Source’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.33M$ 4.17M$ 4.02M$ 3.64M$ 3.81M
Depreciation and Amortization
$ 52.82K$ 4.17M$ 4.02M$ 3.64M$ 3.81M
EBITDA
$ -4.27M$ -4.17M$ -4.02M$ -3.51M$ -4.03M
Operating Income
$ -4.33M$ -4.17M$ -4.02M$ -3.64M$ -3.81M
Other Income/Expenses
$ -996.00K$ -992.00K$ -1.45M$ -922.00K$ -670.00K
Pretax Income
$ -5.32M$ -5.17M$ -5.47M$ -4.56M$ -4.47M
Net Income
$ -5.32M$ -5.17M$ -5.47M$ -4.56M$ -4.47M
Per Share Metrics
Basic EPS
$ -0.17$ -0.15$ -0.19$ -0.19$ -0.18
Diluted EPS
$ -0.17$ -0.15$ -0.19$ -0.19$ -0.18
Weighted Average Shares Outstanding
37.79M 34.84M 28.12M 29.10M 28.33M
Weighted Average Shares Outstanding (Diluted)
37.79M 34.84M 33.12M 29.10M 28.33M
Currency in USD

Cell Source Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis